EQT AB, KKR & Co. and Advent are among suitors that have been studying a potential acquisition of PolyPeptide, people with knowledge of the matter said last week. Any buyout firm pursuing a take-private deal could seek to team up with its billionaire controlling shareholder, Swedish businessman Frederik Paulsen Jr., according to the people.







